Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Neophytides

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Should dopamine agonists be given early or late? A review of nine years experience with bromocriptineA N Lieberman, G Gopinathan, H Hassouri, et al.
Advances in Neurology|January 1, 1984
Pergolide and lisuride in advanced Parkinson's diseaseA N Lieberman, G Gopinathan, A Neophytides, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1983
Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's diseaseJ J Mann, M Stanley, R D Kaplan, et al.
European Neurology|January 1, 1990
Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's diseaseA Lieberman, G Gopinathan, E Miller, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Evaluation of Parkinson's diseaseA Lieberman, M Dziatolowski, G Gopinathan, et al.
Journal of Neuro-Oncology|January 1, 1987
Brain metastases from ovarian cancerJ Ziegler, P Gliedman, D Fass, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1980
Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's diseaseD L Kleinberg, A Lieberman, J Todd, et al.
Annals of Neurology|January 1, 1983
Bromocriptine and lisuride in Parkinson diseaseA N Lieberman, G Gopinathan, A Neophytides, et al.
Clinical Pharmacology and Therapeutics|December 1, 1981
Cardiac effects of pergolideM Leibowitz, A Lieberman, M Goldstein, et al.
Neurology|June 1, 1981
Treatment of advanced Parkinson disease with pergolideA Lieberman, M Goldstein, M Leibowitz, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1984
Should dopamine agonists be given early or late? A review of nine years experience with bromocriptineA N Lieberman, G Gopinathan, H Hassouri, et al.
Advances in Neurology|January 1, 1984
Pergolide and lisuride in advanced Parkinson's diseaseA N Lieberman, G Gopinathan, A Neophytides, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1983
Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's diseaseJ J Mann, M Stanley, R D Kaplan, et al.
European Neurology|January 1, 1990
Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's diseaseA Lieberman, G Gopinathan, E Miller, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Evaluation of Parkinson's diseaseA Lieberman, M Dziatolowski, G Gopinathan, et al.
Journal of Neuro-Oncology|January 1, 1987
Brain metastases from ovarian cancerJ Ziegler, P Gliedman, D Fass, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1980
Pergolide mesylate: a potent day-long inhibitor of prolactin in rhesus monkeys and patients with Parkinson's diseaseD L Kleinberg, A Lieberman, J Todd, et al.
Annals of Neurology|January 1, 1983
Bromocriptine and lisuride in Parkinson diseaseA N Lieberman, G Gopinathan, A Neophytides, et al.
Clinical Pharmacology and Therapeutics|December 1, 1981
Cardiac effects of pergolideM Leibowitz, A Lieberman, M Goldstein, et al.
Neurology|June 1, 1981
Treatment of advanced Parkinson disease with pergolideA Lieberman, M Goldstein, M Leibowitz, et al.
Pageof 4